Researchers discover why Gleevec-type drugs control, but do not eradicate leukaemia

Oregon Health and Science University Knight Cancer Institute researchers are closer to understanding why certain chronic myeloid leukaemia mutations are not stopped by the revolutionary targeted cancer pill, Gleevec, or similar therapies in that drug family...

Read the whole article on

More from